Carl LeBel, Chief Development Officer at Frequency Therapeutics, Inc. (FREQ), sold 844 shares at $4.33 ($4K) on 2022-02-15, disclosed to the SEC on 2022-02-16.
Open-market sale of $4k FREQ by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| FREQ | SELL | 2022-02-18 | $7K | — | Filing → |
| OTIC | SELL | 2016-11-22 | $384K | — | Filing → |
| OTIC | SELL | 2016-09-08 | $381K | — | Filing → |